O-antigen-specific monoclonal antibodies (MAbs) are currently being generated to develop an O-serotyping scheme for the genus Acinetobacter and to provide potent tools to study the diversity of O-antigens among Acinetobacter strains. In this report, Acinetobacter baumannii strains from the Czech Republic and from two clonal groups identified in Northwestern Europe (termed clones I and II) were investigated for their reactivity with a panel of O-antigen-specific MAbs generated against Acinetobacter strains from various species. The bacteria were characterized for their ribotype, biotype, and antibiotic susceptibility and the presence of the 8.7-kb plasmid pAN1. By using the combination of these typing profiles, the Czech strains could be classified into four previously defined groups (A. Nemec, L. Janda, O. Melter, and L. Dijkshoorn, J. Med. Microbiol. 48:287-296, 1999): two relatively homogeneous groups of multiresistant strains (termed groups A and B), a heterogeneous group of other multiresistant strains, and a group of susceptible strains. O-antigen reactivity was observed primarily with MAbs generated against Acinetobacter calcoaceticus and Acinetobacter baumannii strains. A comparison of reaction patterns confirmed the previously hypothesized clonal relationship between group A and clone I strains, which are also similar in other properties. The results show that there is limited O-antigen variability among strains with similar geno- and phenotypic characteristics and are suggestive of a high prevalence of certain A. baumannii serotypes in the clinical environment. It is also shown that O-antigen-specific MAbs are useful for the follow-up of strains causing outbreaks in hospitals.

Division of Medical and Biochemical Microbiology Research Center Borstel Borstel Germany

Zobrazit více v PubMed

Bouvet P J M, Grimont P A D. Taxonomy of the genus Acinetobacter with recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov., and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int J Syst Bacteriol. 1986;36:228–240.

Bouvet P J M, Grimont P A D. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur (Paris) 1987;138:569–578. PubMed

Bouvet P J M, Jeanjean S. Delineation of new proteolytic genomic species in the genus Acinetobacter. Res Microbiol. 1989;140:291–299. PubMed

Dijkshoorn L, Tjernberg I, Pot B, Michel M F, Ursing J, Kersters K. Numerical analysis of cell envelope protein profiles of Acinetobacter strains classified by DNA-DNA hybridization. Syst Appl Microbiol. 1990;13:338–344.

Dijkshoorn L. Acinetobacter—microbiology. In: Bergogne-Bérézin E, Joly-Guillou M L, Towner K J, editors. Acinetobacter: microbiology, epidemiology, infections, management. Boca Raton, Fla: CRC Press; 1996. pp. 37–69.

Dijkshoorn L, Aucken H, Gerner-Smidt P, Janssen P, Kaufmann M E, Garaizar J, Ursing J, Pitt T L. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol. 1996;34:1519–1525. PubMed PMC

Glew R H, Moellering R C, Kunz L J. Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies. Medicine. 1977;56:79–96. PubMed

Hoppe M, Potel J, Malottke R. Clinical importance of Acinetobacter calcoaceticus isolations from blood cultures and venecatheters. Zentbl Bakteriol. 1983;256:80–86. PubMed

Juni E. Genus III. Acinetobacter Brisou and Prévot 1954, 727AL. In: Krieg N R, editor. Bergey's manual of systematic bacteriology. Vol. 1. Baltimore, Md: Williams & Wilkins; 1984. pp. 303–307.

Kuhn H M, Brade L, Appelmelk B J, Kusumoto S, Rietschel E T, Brade H. Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infect Immun. 1992;60:2201–2210. PubMed PMC

Lautrop H. Acinetobacter Brisou and Prévot 1954. In: Buchanan R E, Gibbons N E, editors. Bergey's manual of determinative bacteriology. 8th ed. Baltimore, Md: Williams & Wilkins; 1974. pp. 436–438.

Nemec A, Janda L, Melter O, Dijkshoorn L. Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech Republic. J Med Microbiol. 1999;48:287–296. PubMed

Pantophlet R, Brade L, Brade H. Detection of lipid A by monoclonal antibodies in S-form lipopolysaccharide after acidic treatment of immobilized LPS on Western blot. J Endotoxin Res. 1997;4:89–95.

Pantophlet R, Brade L, Dijkshoorn L, Brade H. Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter. J Clin Microbiol. 1998;36:1245–1250. PubMed PMC

Pantophlet R, Brade L, Brade H. Identification of Acinetobacter baumannii strains with monoclonal antibodies against the O antigens of their lipopolysaccharides. Clin Diagn Lab Immunol. 1999;6:323–329. PubMed PMC

Pantophlet R, Brade L, Brade H. Use of a murine O-antigen-specific monoclonal antibody to identify Acinetobacter strains of unnamed genomic species 13 Sensu Tjernberg and Ursing. J Clin Microbiol. 1999;37:1693–1698. PubMed PMC

Pantophlet R, Haseley S R, Vinogradov E V, Brade L, Holst O, Brade H. Chemical and antigenic structure of the O-polysaccharide of the lipopolysaccharide from two Acinetobacter haemolyticus strains differing only in the anomeric configuration of one glycosyl residue in their O-antigen. Eur J Biochem. 1999;263:587–595. PubMed

Taplin D, Rebell G, Zaias N. The human skin as a source of Mima-Herellea infections. JAMA. 1963;186:166–168. PubMed

Tjernberg I, Ursing J. Clinical strains of Acinetobacter classified by DNA-DNA hybridization. APMIS. 1989;97:595–605. PubMed

Towner K J, Bergogne-Bérézin E, Fewson C A. Acinetobacter: portrait of a genus. In: Towner K J, Bergogne-Bérézin E, Fewson C A, editors. The biology of Acinetobacter: taxonomy, clinical importance, molecular biology, physiology, industrial relevance. New York, N.Y: Plenum Press; 1991. pp. 1–24.

Towner K J. Clinical importance and antibiotic resistance of Acinetobacter spp. J Med Microbiol. 1997;46:721–746. PubMed